Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $308.3 million.

  • Inspire Medical Systems' Cash & Current Investments fell 3081.12% to $308.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $308.3 million, marking a year-over-year decrease of 3081.12%. This contributed to the annual value of $308.3 million for FY2025, which is 3081.12% down from last year.
  • Inspire Medical Systems' Cash & Current Investments amounted to $308.3 million in Q4 2025, which was down 3081.12% from $322.6 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Cash & Current Investments high stood at $467.1 million for Q2 2023, and its period low was $196.3 million during Q2 2022.
  • In the last 5 years, Inspire Medical Systems' Cash & Current Investments had a median value of $390.1 million in 2024 and averaged $351.0 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 13790.05% in 2023, then plummeted by 3156.25% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Cash & Current Investments stood at $214.5 million in 2021, then soared by 110.48% to $451.4 million in 2022, then increased by 1.99% to $460.4 million in 2023, then fell by 3.22% to $445.5 million in 2024, then crashed by 30.81% to $308.3 million in 2025.
  • Its last three reported values are $308.3 million in Q4 2025, $322.6 million for Q3 2025, and $300.9 million during Q2 2025.